Actively hiring
Digital Marketing
Market Research
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
Claritas Rx Named to the 2026 Inc. 5000 List for the Second Consecutive Year
SOUTH SAN FRANCISCO, Calif., August 11, 2026--Claritas Rx, the patient journey experts, announced today it has been named to the 2026 Inc. 5000 list for the second consecutive year, earning a place among America
Read more
Report
Claritas Rx Introduces Consent Clearinghouse to Modernize Patient Consent Management Across Biopharma
Read more
Report
Claritas Rx Unveils Integrated Data and Consent Solution That Drives Higher First Fill Rates and Long-Term Persistence Across Specialty and Rare Brands
Read more
Report
Claritas Announces Global Ad Certification to Power AI Optimization on Amazon Ads
This milestone reflects Claritas' ability to meet the standards required to activate across Amazon Ads owned and operated properties as part of the Amazon Ads Partner Network.
Read more
Report
MAD: Claritas Acquires ArtsAI To Help Drive Personalized Campaigns
Claritas Acquires ArtsAI To Help Drive Personalized Campaigns - 09/14/2023
Read more
Report
Claritas Acquires Measurement Rival ArtsAI To Get In On The AI Boom
Claritas acquired AI-driven marketing automation platform ArtsAI to fortify its personalization, measurement and AI capabilities.
Read more
Report
Claritas Transforms Multi-touch Measurement with the Release of its Attribution 3.0 Solution
New signaling methodology in Version 3.0 more precisely tracks consumer engagement to give marketers even greater insight into which channels contribute the most to salesCincinnati, OH, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Claritas, a data-driven company tha
Read more
Report
Claritas to Expand R-107 Program to Include Treatment of Sepsis, the Leading Cause of Death in COVID-19 Patients
--Claritas Pharmaceuticals, Inc. today announced that, based on significantly positive results in a controlled large animal model of sepsis, the Company will now expand its R-107 development program to include the treatment of COVID-19 related sepsis, the
Read more
Report
Claritas (formerly Kalytera Therapeutics, Inc.) to Collaborate with Salzman Group and Other Companies to Accelerate Development of R-107 for Treatment of Vaccine-Resistant COVID-19, Influenza, and Other Viral Infections
Strategic Collaboration with Salzman Group. To conserve capital and expedite the development of R-107, Claritas is collaborating with the Salzman Group and other companies for the manufacture of R-107, and for the design and completion of clinical studies
Read more
Report
Show more news
Growth
Hiring Momentum
73/100
Growing
Open positions
2
2 opened / 0 closed in 30 days
ATS activity
Every ~7 hours
Today
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Marketing
50% ▲
Sales
50% ▲
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Cincinnati
United States
Regional office
8044 Montgomery Road, Suite 455, Cincinnati, OH 45236 USA
